Department of General Psychiatry, St George's Hospital Medical School
MRC Biostatistics Unit, Institute of Public Health, Cambridge
Centre for the Economics of Mental Health, Institute of Psychiatry, London
Department of General Psychiatry, St George's Hospital Medical School, London
School of Psychiatry and Behavioural Sciences, Manchester Royal Infirmary
Institute of Psychiatry, King's College, London, UK
Correspondence: Professor Tom Burns, Department of General Psychiatry, St George's Hospital Medical School, Cranmer Terrace, London SW17 ORE, UK. Tel: 020 8725 5547; fax: 020 8725 3538
Background Trials in community psychiatry must balance rigour with generalisability. The UK700 trial failed to find a significant effect on hospitalisation, but its sample population contained significant heterogeneity of exposure to case management in the two groups.
Aims To test whether patients successfully exposed to a minimum of 12 months' intensive case management over the 2-year follow-up period achieved reduced hospitalisation.
Method Of 679 participants with hospitalisation data, 84 were identified as having < 12 months' exposure owing to prolonged hospitalisation, imprisonment or a combination of the two. These patients were excluded and outcomes tested for the remaining 595 patients.
Results Overall reduced case-load size did not reduce hospitalisation or treatment costs over 2 years despite elimination of outliers. Age, previous hospitalisation and source of recruitment to the study all correlated with outcome.
Conclusions Case-load reduction is not in itself enough to reduce the need for hospital care in psychosis. Baseline patient characteristics (in particular length of previous hospitalisation and recruitment from in-patient care) have a significant influence and should be allowed for in power calculations. Identifying the optimal clinical profile for patients likely to benefit from intensive case management remains a pressing need for further studies.
Related articles in BJP:
This article has been cited by other articles:
![]() |
G. Goodwin and Consensus Group of the British Association for Psy Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology J Psychopharmacol, June 1, 2009; 23(4): 346 - 388. [Abstract] [PDF] |
||||
![]() |
I. R White Uses and limitations of randomization-based efficacy estimators Statistical Methods in Medical Research, August 1, 2005; 14(4): 327 - 347. [Abstract] [PDF] |
||||
![]() |
G. M. Goodwin Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology J Psychopharmacol, June 1, 2003; 17(2): 149 - 173. [Abstract] [PDF] |
||||
![]() |
OTHER ARTICLES NOTED (25 Oct 02 to 17 Jan 03) Evid. Based Nurs., April 1, 2003; 6(2): e1 - 7. [Full Text] |
||||